Analysis of the expression in platelets membrane glycoprotein of the MYH9-RD family by flowcytometry
Shufang Zhang, Shun-lan Wang, Ying-ai Zhang, Jing-chuan Xiao
Abstract
Shufang Zhang, Shun-lan Wang, Ying-ai Zhang, Jing-chuan Xiao
Abstract
Objective To explore the pathogenic mechanism by detecting the expression of membrane glycoprotein in the platelets of nonmuscle myosin heavy chain 9 related disease (MYH9-RD) patients. Methods Periperal bloods were obtained from 11 MYH9-RD patients and 7 normal family members.Flow cytometry was used for detecting the expression of the platelet membrane glycoprotein including GPⅡb/Ⅲa(CD41/61) ,GPⅠa(CD49b) , GPⅠb/Ⅸ/Ⅴ(CD42a)GPⅠb(CD42b) and GPⅣ(CD36). Results The expression fluorescence intensity of platelet membrane glycoprotein GPⅡb/Ⅲa(CD41/61), GPIa(CD49b), GPⅠb/Ⅸ/Ⅴ(CD42a)GPⅠb(CD42b) and GPⅣ(CD36) are 653.7±192.7,420.0±151.3,667.7±371.3 and 236.4±64.2 respectively ,which are significantly higher than those in normal controls (406.7±126.1,181.2±29.3,271.4±91.6 and 136.1±23.5;P 0.05). Conclusion In our study,the diverse clinical manifestations in patients with MYH9-RD is probably associated with the expression level of platelet membrane glycoprotein(Chin J Lab Med,2012,35:1159-1162) Key words: Thrombocytopenia; Platelet membrane glycoproteins; Myosin heavy chains; Molecular motor proteins; Flow cytometry
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the pathogenic mechanism by detecting the expression of membrane glycoprotein in the platelets of nonmuscle myosin heavy chain 9 related disease (MYH9-RD) patients. Methods Periperal bloods were obtained from 11 MYH9-RD patients and 7 normal family members.Flow cytometry was used for detecting the expression of the platelet membrane glycoprotein including GPⅡb/Ⅲa(CD41/61) ,GPⅠa(CD49b) , GPⅠb/Ⅸ/Ⅴ(CD42a)GPⅠb(CD42b) and GPⅣ(CD36). Results The expression fluorescence intensity of platelet membrane glycoprotein GPⅡb/Ⅲa(CD41/61), GPIa(CD49b), GPⅠb/Ⅸ/Ⅴ(CD42a)GPⅠb(CD42b) and GPⅣ(CD36) are 653.7±192.7,420.0±151.3,667.7±371.3 and 236.4±64.2 respectively ,which are significantly higher than those in normal controls (406.7±126.1,181.2±29.3,271.4±91.6 and 136.1±23.5;P 0.05). Conclusion In our study,the diverse clinical manifestations in patients with MYH9-RD is probably associated with the expression level of platelet membrane glycoprotein(Chin J Lab Med,2012,35:1159-1162) Key words: Thrombocytopenia; Platelet membrane glycoproteins; Myosin heavy chains; Molecular motor proteins; Flow cytometry
Key concepts: Platelet membrane glycoprotein, Membrane glycoproteins, Flow cytometry, Platelet, Glycoprotein, Molecular biology, CD36, Chemistry